How to manage vasopressors in acute renal failure and septic shock

Contributions to Nephrology

Volumn 144, Issue , 2004, Pages 182-190

  Dana, Maurizio ^a   Rossia, Sandra ^a   Callegarina, Luca ^a   Ronco, Claudio ^a  

^a Ospedale di Vicenza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ACUTE KIDNEY FAILURE; BLOOD CLOTTING DISORDER; HUMAN; INFECTION; REVIEW; SEPTIC SHOCK;

BLOOD COAGULATION DISORDERS; CARDIOVASCULAR AGENTS; HUMANS; INFECTION; KIDNEY FAILURE, ACUTE; SHOCK, SEPTIC;

EID: 3343000398     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (27)

1. Brivet FG, Kleinknecht DJ, Loirat P: Acute renal failure in intensive care units: Causes, outcome, and prognostic factors of hospital mortality: A prospective multicenter study. Crit Care Med 1996;24:192-198.
2. Brezis M, Rosen S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 1995;332:647-655.
3. Myers BD, Moran SM: Hemodynamically mediated acute renal failure. N Engl J Med 1986;314:97-105.
4. Parrillo JE: Septic shock in humans: Advances in understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-242.
5. Parker MM, Suffredini AF, Natanson C, et al: Response of left ventricular function in survivors and non survivors of septic shock. J Crit Care 1989;4:19-25.
6. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterizes the cardiac depression of septic shock in humans. Chest 1990;97:126-132.
7. Ince C, Sinaasappel M: Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999;27:1369-1377.
8. Ince C: Microcirculatory weak units: An alternative explanation. Crit Care Med 2000;28:3128-3129.
9. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025-1032.
10. Daemen MJ, De May JG: Regional heterogeneity of arterial structure changes. Hypertension 1995;25:464-473.
11. O'Rourke MF, Safar ME, Dzau VJ: Arterial Vasodilatation: Mechanism and Therapy. London, Edward Arnold, 1993.
12. Heyman SN, Fuchs S, Brezis M: The role of medullary ischemia in acute renal failure. New Horizons 1995;3:597-607.
13. Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997;112:235-243.
14. Landry DW, Lewin HR, Gallant EM, et al: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-1282.
15. Landry DW, Lewin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-1125.
16. Murray PT, Wylam ME, Umans JG: Nitric oxide and septic vascular dysfunction. Anesth Analg 2000;90:89-101.
17. Mulder MF, Van Lambalgen AA, Huisman E, et al: Protective role of NO in the regional hemodynamic change during acute endotoxemia in rats. Am J Physiol 1994;266:1558-1564.
18. Nichols WW, O'Rourke MF: McDonald's Blood Flow in Arteries, ed 4. London, Arnold, 1998, pp 284-293.
19. Nichols WW, O'Rourke MF: McDonald's Blood Flow in Arteries, ed 4. London, Arnold, 1998, pp 294-295.
20. Cholley B, Lang R, Berger D, et al: Alterations in systemic arterial mechanical properties during septic shock: Role of fluid resuscitation. Am J Physiology 1995;269:H375-H384.
21. Russell JA, Cooper DJ, Walley KR, et al: Vasopressin and septic shock trial (VASST): baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Resp Crit Care Med 2003;167:A548.
22. Bellomo R, Ronco C: The Use of Inotropic and Vasopressor Agents in Patients at Risk of Renal Dysfunction. Critical Care Nephrology. Amsterdam, Kluwer Academic Publishers, 1998, pp 1133-1137.
23. Bellomo R, Kellum JA, Wisniewski SR, et al: Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Resp Crit Care Med 1999;28:2758-2765.
24. Di Giantomasso D, Morimatsu H, May CN, Bellomo R: Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 2003;31:2509-2513.
25. Di Giantomasso D, May CN, Bellomo R: Vital organ blood flow durino hyperdynamic sepsis. Chest 2003;124:1053-1059.
26. Martin C, Viviand X, Leone M, Thirion X: Effect of norepinephine on the outcome of septic shock. Crit Care Med 2000;28:2758-2765.
27. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993;103:1826-1831.